ALLO
Price
$3.04
Change
-$0.32 (-9.52%)
Updated
Apr 24, 6:59 PM EST
6 days until earnings call
SGMO
Price
$0.49
Change
-$0.03 (-5.77%)
Updated
Apr 24, 6:59 PM EST
7 days until earnings call
Ad is loading...

Analysis and predictions ALLO vs SGMO

Header iconALLO vs SGMO Comparison
Open Charts ALLO vs SGMOBanner chart's image
Allogene Therapeutics
Price$3.04
Change-$0.32 (-9.52%)
Volume$1.35M
CapitalizationN/A
Sangamo Therapeutics
Price$0.49
Change-$0.03 (-5.77%)
Volume$825.54K
CapitalizationN/A
View a ticker or compare two or three
ALLO vs SGMO Comparison Chart

Loading...

ALLODaily Signal changed days agoGain/Loss if shorted
 
Show more...
SGMODaily Signal changed days agoGain/Loss if shorted
 
Show more...
VS
ALLO vs. SGMO commentary
Apr 25, 2024

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is ALLO is a Hold and SGMO is a Hold.

COMPARISON
Comparison
Apr 25, 2024
Stock price -- (ALLO: $3.37 vs. SGMO: $0.52)
Brand notoriety: ALLO and SGMO are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: ALLO: 72% vs. SGMO: 106%
Market capitalization -- ALLO: $519M vs. SGMO: $102.3M
ALLO [@Biotechnology] is valued at $519M. SGMO’s [@Biotechnology] market capitalization is $102.3M. The market cap for tickers in the [@Biotechnology] industry ranges from $567.76B to $0. The average market capitalization across the [@Biotechnology] industry is $2.55B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

ALLO’s FA Score shows that 0 FA rating(s) are green whileSGMO’s FA Score has 1 green FA rating(s).

  • ALLO’s FA Score: 0 green, 5 red.
  • SGMO’s FA Score: 1 green, 4 red.
According to our system of comparison, SGMO is a better buy in the long-term than ALLO.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

ALLO’s TA Score shows that 4 TA indicator(s) are bullish while SGMO’s TA Score has 5 bullish TA indicator(s).

  • ALLO’s TA Score: 4 bullish, 4 bearish.
  • SGMO’s TA Score: 5 bullish, 5 bearish.
According to our system of comparison, both ALLO and SGMO are a good buy in the short-term.

Price Growth

ALLO (@Biotechnology) experienced а -3.71% price change this week, while SGMO (@Biotechnology) price change was -3.89% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +0.41%. For the same industry, the average monthly price growth was -3.09%, and the average quarterly price growth was +1263.37%.

Reported Earning Dates

ALLO is expected to report earnings on Aug 07, 2024.

SGMO is expected to report earnings on Aug 07, 2024.

Industries' Descriptions

@Biotechnology (+0.41% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
A.I.dvisor published
a Summary for ALLO with price predictions.
OPEN
A.I.dvisor published
a Summary for SGMO with price predictions.
OPEN
FUNDAMENTALS
Fundamentals
ALLO($519M) has a higher market cap than SGMO($108M). ALLO YTD gains are higher at: 4.984 vs. SGMO (-4.123).
ALLOSGMOALLO / SGMO
Capitalization519M108M481%
EBITDAN/AN/A-
Gain YTD4.984-4.123-121%
P/E RatioN/AN/A-
RevenueN/AN/A-
Total CashN/AN/A-
Total DebtN/AN/A-
FUNDAMENTALS RATINGS
SGMO: Fundamental Ratings
SGMO
OUTLOOK RATING
1..100
53
VALUATION
overvalued / fair valued / undervalued
1..100
22
Undervalued
PROFIT vs RISK RATING
1..100
100
SMR RATING
1..100
99
PRICE GROWTH RATING
1..100
64
P/E GROWTH RATING
1..100
100
SEASONALITY SCORE
1..100
n/a

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

TECHNICAL ANALYSIS
Technical Analysis
ALLOSGMO
RSI
ODDS (%)
Bullish Trend 2 days ago
90%
N/A
Stochastic
ODDS (%)
Bullish Trend 2 days ago
80%
Bullish Trend 2 days ago
72%
Momentum
ODDS (%)
N/A
Bearish Trend 2 days ago
86%
MACD
ODDS (%)
N/A
Bullish Trend 2 days ago
78%
TrendWeek
ODDS (%)
Bearish Trend 2 days ago
85%
Bearish Trend 2 days ago
89%
TrendMonth
ODDS (%)
Bearish Trend 2 days ago
84%
Bearish Trend 2 days ago
87%
Advances
ODDS (%)
Bullish Trend 28 days ago
81%
Bullish Trend 28 days ago
73%
Declines
ODDS (%)
Bearish Trend 2 days ago
82%
Bearish Trend 7 days ago
88%
BollingerBands
ODDS (%)
Bullish Trend 2 days ago
82%
Bullish Trend 2 days ago
79%
Aroon
ODDS (%)
Bearish Trend 2 days ago
89%
Bearish Trend 2 days ago
89%
View a ticker or compare two or three
Ad is loading...
ALLODaily Signal changed days agoGain/Loss if shorted
 
Show more...
SGMODaily Signal changed days agoGain/Loss if shorted
 
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
AYASF10.130.33
+3.40%
AYA Gold & Silver
ATEYY34.310.30
+0.87%
Advantest Corp
NYMXF0.30N/A
N/A
NYMOX PHARMACEUTICAL Corp
NTTYY27.70-0.11
-0.40%
Nippon Telegraph and Telephone Corp
SHTDY13.32-0.14
-1.07%
Sinopharm Group Co Ltd

ALLO and

Correlation & Price change

A.I.dvisor indicates that over the last year, ALLO has been loosely correlated with NTLA. These tickers have moved in lockstep 61% of the time. This A.I.-generated data suggests there is some statistical probability that if ALLO jumps, then NTLA could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To ALLO
1D Price
Change %
ALLO100%
-0.88%
NTLA - ALLO
61%
Loosely correlated
-1.37%
BEAM - ALLO
55%
Loosely correlated
-2.61%
DNLI - ALLO
50%
Loosely correlated
+0.75%
CTMX - ALLO
48%
Loosely correlated
+0.60%
EDIT - ALLO
48%
Loosely correlated
-2.50%
More

SGMO and

Correlation & Price change

A.I.dvisor indicates that over the last year, SGMO has been loosely correlated with AXON. These tickers have moved in lockstep 51% of the time. This A.I.-generated data suggests there is some statistical probability that if SGMO jumps, then AXON could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To SGMO
1D Price
Change %
SGMO100%
+2.12%
AXON - SGMO
51%
Loosely correlated
+2.64%
ARRY - SGMO
48%
Loosely correlated
+2.14%
BCRX - SGMO
46%
Loosely correlated
-0.68%
RPRX - SGMO
45%
Loosely correlated
N/A
AGEN - SGMO
43%
Loosely correlated
+11.96%
More